Precision BioSciences Announces Initial Safety and Antiviral Activity

Yes, we have described it here: Ausperbio announces AHB-137 Monotherapy achieves 30% functional cure in HBe-negative CHB patients on stable NA therapy - #5 by Nawab

Indeed, very interested in seeing progress in this area.

My understanding is that there are a few modifications that make it a little more stable, but it is the same active molecule

TT

2 Likes